Aspire Private Capital’s First Trust Health Care AlphaDEX Fund FXH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-121
Closed -$13K 562
2020
Q4
$13K Buy
121
+5
+4% +$509 0.01% 257
2020
Q3
$11K Sell
116
-1
-0.9% -$94 ﹤0.01% 271
2020
Q2
$11K Sell
117
-1,665
-93% -$143K 0.01% 204
2020
Q1
$132K Buy
1,782
+387
+28% +$31.4K 0.07% 101
2019
Q4
$117K Sell
1,395
-1,134
-45% -$89.8K 0.05% 154
2019
Q3
$187K Sell
2,529
-98
-4% -$7.47K 0.09% 103
2019
Q2
$203K Sell
2,627
-883
-25% -$65.6K 0.1% 109
2019
Q1
$268K Sell
3,510
-315
-8% -$23.5K 0.14% 101
2018
Q4
$263K Buy
+3,825
New +$290K 0.15% 103

Other funds holding FXH

Aspire Private Capital's FXH Position: Q1 2021 in Review

Aspire Private Capital sold out of First Trust Health Care AlphaDEX Fund (FXH) in Q1 2021, closing a stake of 121 shares — an estimated $13K sold.

Aspire Private Capital first reported a position in FXH in Q4 2018 and held it in 9 quarters. The position peaked at $268K in Q1 2019. 209 funds tracked by Wall St. Rank hold FXH as of Q1 2021.

  • Aspire Private Capital reported no remaining First Trust Health Care AlphaDEX Fund position as of Q1 2021 after selling out during the quarter.
  • Aspire Private Capital sold 121 First Trust Health Care AlphaDEX Fund shares in Q1 2021, an estimated $13K.
  • Aspire Private Capital first reported a position in First Trust Health Care AlphaDEX Fund in Q4 2018 and held it in 9 quarters.
  • Aspire Private Capital's First Trust Health Care AlphaDEX Fund position peaked at $268K in Q1 2019.
  • 209 funds tracked by Wall St. Rank held First Trust Health Care AlphaDEX Fund as of Q1 2021.

Based on Aspire Private Capital's 13F filing for Q1 2021, filed 26 May 2021.